24Mar/21
Protein Degrader, a Frontier Small Molecule Drug
On December 14, 2020, Arvinas, a pioneer of Protein Degrader, announced the results of phase I clinical trials of new Protein Degrader drugs ARV-471 and ARV-110, of which ARV-471 showed outstanding efficacyRead More…